Drug pricing

News

Pharma CEOs may be subpoenaed as IRA dispute rumbles on

US Senator Bernie Sanders has said he plans to hold a vote on 31st January to subpoena the chief executives of Johnson & Johnson and Merck & Co for a hearing on dr

News

Florida is first US state cleared to import Canadian drugs

The FDA has approved the first request from a US state to import prescription medicines from Canada, giving the green light to Florida for a programme that aims to reduce

News

AbbVie hit as CVS says it will cut Humira from formularies

CVS Health has said it will remove AbbVie’s big-selling immunology drug Humira from most of its national formulary lists of reimbursable products, and offer biosimilar ver

News

White House says 48 drugs are heading for Medicare rebates

The Biden administration has generated a list of 48 drugs whose prices were raised faster than inflation in the last quarter of this year and may be subject to the mandato

News

Eisai sets Leqembi price in Japan at a discount to US

Eisai and Biogen’s Alzheimer’s disease therapy Leqembi is due to be launched in Japan, its second market, on 20th December, and will be priced quite a lot lower there than

News

Biden may order compulsory licensing in drug pricing move

The White House said today that it may take enforced ownership of patents on medicines developed with public funding if their manufacturers set their prices too high.

Pharma CEOs may be subpoenaed as IRA dispute rumbles on

Florida is first US state cleared to import Canadian drugs

AbbVie hit as CVS says it will cut Humira from formularies

White House says 48 drugs are heading for Medicare rebates

Eisai sets Leqembi price in Japan at a discount to US

Biden may order compulsory licensing in drug pricing move

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Drug pricing

Editor's Picks